Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. Recent highlights for the company […]
Beta Bionics
Beta Bionics goes public with upsized $204M IPO
Beta Bionics (Nasdaq:BBNX) has gone public after pricing a significantly upsized initial public offering (IPO). Our sibling site Drug Delivery Business News reported the news today, which is Beta Bionics’ first day of trading. Earlier this month, the company filed a registration statement with the SEC relating to a proposed IPO. Beta Bionics, maker of the […]
Beta Bionics to raise $114.4M in IPO
Beta Bionics today provided more details related to its plans to raise funds through an initial public offering (IPO). Earlier this month, the maker of the iLet bionic pancreas filed a registration statement with the SEC relating to a proposed IPO. Our sister site, Drug Delivery Business News reports today that the company filed a prospectus […]
Beta Bionics is proposing an IPO
Beta Bionics, a significant player in the automated insulin delivery space, announced that it aims to become a publicly traded company. Our sister site, Drug Delivery Business News, reports today that the company filed a registration statement with the SEC relating to a proposed initial public offering (IPO). Irvine, California-based Beta Bionics filed to list its […]
Xeris, Beta Bionics collab on glucagon product for pumps
Xeris and Beta Bionics today announced an exclusive worldwide collaboration to develop a glucagon product for proprietary pump technology. The collaboration and license agreement covers the development and commercialization of a glucagon product utilizing the Xeris XeriSol technology. Xeris and Beta Bionics aim to utilize the product with proprietary bi-hormonal pump and pump systems. Glucagon, […]
These diabetes devices are set to launch in 2024
The diabetes space continues to innovate, and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year. At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year. Some of those stories didn’t end in 2023, though, as a few […]
The 10 biggest diabetes tech stories from 2023
It was another banner year for diabetes technology, with regulatory approvals, product launches and M&A all playing their part. Diabetes technology’s impressive 12 months marked a major trend across medtech as a whole, too. In 2022, the diabetes space saw plenty of progress from some of its biggest names and this past year proved no different. […]
Beta Bionics integrates iLet bionic pancreas with Dexcom G7
Beta Bionics announced today that it began the U.S. launch of its iLet bionic pancreas with the Dexcom G7 continuous glucose monitor (CGM). The launch marks the second G7-compatible automated insulin delivery system to hit the market in as many days. Yesterday, Tandem Diabetes Care became the first to launch an artificial pancreas using Dexcom’s […]
Beta Bionics earns pharmacy benefit win for bionic pancreas
Beta Bionics announced that Express Scripts added its iLet bionic pancreas and associated supplies to its commercial national formulary offerings. The decision enables faster and easier access to iLet for eligible users with plans that cover the system under their pharmacy benefit. It marks more good news for Beta Bionics, which closed a $100 million […]
Beta Bionics closes $100M Series D to support bionic pancreas
Beta Bionics announced that it successfully closed a Series D funding round, securing $100 million in new equity capital. Concord, Massachusetts-based Beta Bionics develops its flagship iLet bionic pancreas. The autonomous insulin delivery system streamlines diabetes management and reduces the burden on patients and physicians. iLet received FDA clearance in May. While Beta Bionics did […]
8 drug delivery innovations you should know
Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight. Constant progress continues in the diabetes space, both in the form of insulin delivery and other drug delivery methods. Elsewhere, we see implants, patches, syringes and more showcasing the many ways we can […]
